pubmed-article:15234398 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0190211 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0247025 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1511237 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1705509 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0725066 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1550436 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
pubmed-article:15234398 | lifeskim:mentions | umls-concept:C0442796 | lld:lifeskim |
pubmed-article:15234398 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15234398 | pubmed:dateCreated | 2004-7-5 | lld:pubmed |
pubmed-article:15234398 | pubmed:abstractText | We sought to determine the safety and efficacy of high-dose bolus (HDB) tirofiban in high-risk patients undergoing percutaneous coronary intervention (PCI). | lld:pubmed |
pubmed-article:15234398 | pubmed:language | eng | lld:pubmed |
pubmed-article:15234398 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15234398 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15234398 | pubmed:month | Jul | lld:pubmed |
pubmed-article:15234398 | pubmed:issn | 0735-1097 | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:FerrariFabriz... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:FerrariRobert... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:ParrinelloGio... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:ValgimigliMar... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:GuardigliGabr... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:Soukhomovskai... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:PercocoGianfr... | lld:pubmed |
pubmed-article:15234398 | pubmed:author | pubmed-author:BarbieriDario... | lld:pubmed |
pubmed-article:15234398 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15234398 | pubmed:day | 7 | lld:pubmed |
pubmed-article:15234398 | pubmed:volume | 44 | lld:pubmed |
pubmed-article:15234398 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15234398 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15234398 | pubmed:pagination | 14-9 | lld:pubmed |
pubmed-article:15234398 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:meshHeading | pubmed-meshheading:15234398... | lld:pubmed |
pubmed-article:15234398 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15234398 | pubmed:articleTitle | The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. | lld:pubmed |
pubmed-article:15234398 | pubmed:affiliation | Department of Cardiology, University of Ferrara, Ferrara, Italy. vlgmrc@unife.it | lld:pubmed |
pubmed-article:15234398 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15234398 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15234398 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15234398 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15234398 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15234398 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15234398 | lld:pubmed |